KALLEN; Jorg
Patent Applications and Registrations
Patent applications and USPTO patent grants for KALLEN; Jorg.The latest application filed is for "1h-quinazoline-2,4-diones".
- KALLEN; Jorg - Basel CH
| Patent | Date |
|---|---|
| 1h-quinazoline-2,4-diones App 20130296332 - ALLGEIER; Hans ; et al. | 2013-11-07 |
| 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy Grant 8,513,268 - Allgeier , et al. August 20, 2 | 2013-08-20 |
| 1h-quinazoline-2,4-diones App 20110294818 - Allgeier; Hans ; et al. | 2011-12-01 |
| 3-imidazolyl-indoles for the treatment of proliferative diseases Grant 8,053,457 - Boettcher , et al. November 8, 2 | 2011-11-08 |
| N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-q- uinazolin-3-yl)methanesulfonamide Grant 8,012,988 - Allgeier , et al. September 6, 2 | 2011-09-06 |
| 1h-quinaz0line-2,4-diones App 20100144747 - ALLGEIER; Hans ; et al. | 2010-06-10 |
| 3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases App 20100125064 - Boettcher; Andreas ; et al. | 2010-05-20 |
| Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands Grant 7,655,666 - Allgeier , et al. February 2, 2 | 2010-02-02 |
| 1H-Quinazoline-2,4-Diones App 20080153836 - Allgeier; Hans ; et al. | 2008-06-26 |
| Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha) App 20050165218 - Beerli, Rene ; et al. | 2005-07-28 |
| Melvinolin derivatives Grant 6,818,638 - Baenteli , et al. November 16, 2 | 2004-11-16 |
| Lymphocyte function antigen-1 antagonists Grant 6,630,492 - Bauer , et al. October 7, 2 | 2003-10-07 |
| Mevinolin derivatives App 20030087903 - Baenteli, Rolf ; et al. | 2003-05-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 